Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Pozdeyev, Nikita University Of Colorado Denver United States Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc. Punnen, Sanoj University Of Miami School Of Medicine United States The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 5R01CA272766-03 Matthew Young, Ph.D. Reuland, Daniel S. Univ Of North Carolina Chapel Hill United States Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) 5UG1CA286949-03 Elyse LeeVan, M.D., M.P.H. Ricciardiello, Luigi University Of Tx Md Anderson Can Ctr United States Great Lakes New England Clinical Validation Center 4U01CA086400-24 Matthew Young, Ph.D. Ricciardiello, Luigi University Of Tx Md Anderson Can Ctr United States Great Lakes New England Clinical Validation Center 4U01CA086400-24 Matthew Young, Ph.D. Richards-Kortum, Rebecca R. Rice University United States Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique 3U01CA292741-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. Robbins, Hilary A. International Agency For Res On Cancer United States The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening 4R01CA262164-04 Claire Zhu, Ph.D. Robertson, Sarah E Dartmouth College United States Learning about the effectiveness of lung cancer screening in real-world target populations 4R00CA287059-03 Neeraj Saxena, Ph.D. Rotemberg, Veronica Miriam Sloan-Kettering Inst Can Research United States M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-04 Guillermo Marquez, Ph.D. Saenger, Yvonne Margaret Albert Einstein College Of Medicine United States Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-05 Guillermo Marquez, Ph.D. Salami, Simpa Samuel University Of Michigan At Ann Arbor United States Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-03 Guillermo Marquez, Ph.D. Salipante, Stephen J University Of Washington United States Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation 1R33CA302385-01 Nicholas Hodges, Ph.D. Salkowski, Lonie University Of Wisconsin-Madison United States Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection 5R37CA262110-04 Guillermo Marquez, Ph.D. Sanda, Martin G Emory University United States Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc. Sanda, Martin G Emory University United States Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc. Pagination « First First page ‹ Previous Previous page … 8 9 10 11 … Next › Next page Last » Last page
